Medetomidine, a powerful tranquilizer that started to spread as an adulterant in the illicit opioid supply two years ago, causes excruciating, complicated withdrawal symptoms, often within hours of someone’s last dose. With support from the Fund, Hannah Harris Green reported for STAT that many institutions – particularly jails and prisons – are ill-prepared to treat the withdrawal effects of this new drug.
Jails are unprepared for dangerous new type of drug withdrawal, grantee finds
